BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38336127)

  • 21. Utilization of a novel humble inquiry interview approach in assessing implementation barriers to a nurse-driven Clostridioides difficile test order set.
    Kon S; Fisher S; Ngo N; Craig R; Gunter C; Bessesen M; Gilmartin H
    Am J Infect Control; 2023 Nov; 51(11):1288-1290. PubMed ID: 37257565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of hospital environment and the hands of medical staff in the transmission of the
    Kabała M; Aptekorz M; Martirosian G
    Med Pr; 2019 Dec; 70(6):739-745. PubMed ID: 31535670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of control interventions on Clostridium difficile infection in England: an observational study.
    Dingle KE; Didelot X; Quan TP; Eyre DW; Stoesser N; Golubchik T; Harding RM; Wilson DJ; Griffiths D; Vaughan A; Finney JM; Wyllie DH; Oakley SJ; Fawley WN; Freeman J; Morris K; Martin J; Howard P; Gorbach S; Goldstein EJC; Citron DM; Hopkins S; Hope R; Johnson AP; Wilcox MH; Peto TEA; Walker AS; Crook DW;
    Lancet Infect Dis; 2017 Apr; 17(4):411-421. PubMed ID: 28130063
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Cofini V; Muselli M; Gentile A; Lucarelli M; Lepore RA; Micolucci G; Necozione S
    J Prev Med Hyg; 2021 Jun; 62(2):E514-E519. PubMed ID: 34604594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of pulsed xenon ultraviolet disinfection for Clostridioides (Clostridium) difficile surface contamination in a Japanese hospital.
    Kitagawa H; Mori M; Hara T; Kashiyama S; Shigemoto N; Ohge H
    Am J Infect Control; 2021 Jan; 49(1):55-58. PubMed ID: 32485271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium Difficile: Reducing Infections Using an Evidence-Based Practice Initiative.
    Nielsen CSR; Sanchez-Vargas R; Perez A
    Clin J Oncol Nurs; 2019 Oct; 23(5):482-487. PubMed ID: 31538977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Japanese Society for infection prevention and control guide to Clostridioides difficile infection prevention and control.
    Kunishima H; Ichiki K; Ohge H; Sakamoto F; Sato Y; Suzuki H; Nakamura A; Fujimura S; Matsumoto K; Mikamo H; Mizutani T; Morinaga Y; Mori M; Yamagishi Y; Yoshizawa S
    J Infect Chemother; 2024 Aug; 30(8):673-715. PubMed ID: 38714273
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of hospital-onset Clostridium difficile infection in the New York metropolitan region using a collaborative intervention model.
    Koll BS; Ruiz RE; Calfee DP; Jalon HS; Stricof RL; Adams A; Smith BA; Shin G; Gase K; Woods MK; Sirtalan I
    J Healthc Qual; 2014; 36(3):35-45. PubMed ID: 23294050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained reductions in unnecessary antimicrobial administration and hospital
    Gaffin N; Spellberg B
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):491-493. PubMed ID: 34915961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental services impact on healthcare-associated Clostridium difficile reduction.
    Daniels T; Earlywine M; Breeding V
    Am J Infect Control; 2019 Apr; 47(4):400-405.e1. PubMed ID: 30554878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients.
    Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A
    Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospital resource endowments and nosocomial infections: longitudinal evidence from the English National Health Service on Clostridioides difficile between 2011 and 2019.
    Stead S; Vogt L; Antons D; Salge TO; Gecht J; Klasen M; Sopka S
    J Hosp Infect; 2023 Apr; 134():129-137. PubMed ID: 36750139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
    Savage TJ; Sandora TJ
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, epidemiology and control of
    Singhal T; Shah S; Tejam R; Thakkar P
    Indian J Med Microbiol; 2018; 36(3):381-384. PubMed ID: 30429391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of an aerosolized hydrogen peroxide disinfection system for the reduction of Clostridioides difficile hospital infection rates over a 10 year period.
    Truitt CL; Runyan DA; Stern JJ; Tobin C; Goldwater W; Madsen R
    Am J Infect Control; 2022 Apr; 50(4):409-413. PubMed ID: 35307211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting.
    Dantes R; Epson EE; Dominguez SR; Dolan S; Wang F; Hurst A; Parker SK; Johnston H; West K; Anderson L; Rasheed JK; Moulton-Meissner H; Noble-Wang J; Limbago B; Dowell E; Hilden JM; Guh A; Pollack LA; Gould CV
    Am J Infect Control; 2016 Feb; 44(2):138-45. PubMed ID: 26601705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Statewide Prevention and Reduction of
    Rock C; Perlmutter R; Blythe D; Bork J; Claeys K; Cosgrove SE; Dzintars K; Fabre V; Harris AD; Heil E; Hsu YJ; Keller S; Maragakis LL; Milstone AM; Morgan DJ; Dullabh P; Ubri PS; Rotondo C; Brooks R; Leekha S
    BMJ Qual Saf; 2022 Feb; 31(2):153-162. PubMed ID: 34887357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A
    Spagnolo AM; Sartini M; Battistella A; Casini B; Lo Pinto G; Schinca E; Cristina ML;
    J Prev Med Hyg; 2018 Jun; 59(2):E132-E138. PubMed ID: 30083620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of health care facility-onset Clostridioides difficile infection (CDI) in a hematopoietic cell transplant (HCT) unit: A call for diagnostic stewardship in a complex patient population.
    Swetky M; Wilson MH; Douglas P; Milstein A; Olson S; Ueda Oshima M; Tverdek F; Walji S; Liu C; Pergam SA
    Am J Infect Control; 2024 Mar; 52(3):374-376. PubMed ID: 38061404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.